跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,541 条关于
“D2 dopamine receptors”
全部
6,541
临床试验
4,052
药物
769
机构
7
资讯
1,713
去年
IQVIA Gains CDSCO Panel Approval for Phase III Lumateperone Trial in Pediatric Bipolar Depression
去年
Neumora Therapeutics Initiates Phase 1 Trial of Novel M4 Receptor Modulator NMRA-861 for Schizophrenia
去年
FDA Approvals in 2024: NASH Treatment, DMD Therapy, Novel Schizophrenia Drug, and Breast Cancer Advancement
10个月前
Neumora Therapeutics Initiates Phase 1 Trial for Second M4 Muscarinic Receptor Modulator NMRA-898
去年
Bristol Myers Squibb Soars as AbbVie's Schizophrenia Drug Fails Trial
2年前
TAK-906: Peripheral D2/D3 Antagonist Under Development for Gastroparesis
6个月前
Emalex Biosciences Initiates Expanded Access Program for Novel Tourette Syndrome Therapy Ecopipam
2年前
BMS Acquires Karuna Therapeutics for $14 Billion, Betting on Novel Schizophrenia Drug KarXT
7个月前
CBD Shows Promise in Reducing Fetal Alcohol Spectrum Disorder Effects Through Endocannabinoid System Modulation
11个月前
FDA Authorizes Expanded Access Program for First-in-Class Tourette Syndrome Drug Ecopipam
第 1 页,共 172 页
上一页
下一页